Making sense of blood pressure values in follow-up appointments for hypertension

International Journal of Cardiology

Volumn 123, Issue 2, 2008, Pages 108-116

  Svensson, Staffan ^a   Linell, Per ^b   Kjellgren, Karin I ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Communication; Decision making; Hypertension; Negotiation

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; DECISION MAKING; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SWEDEN; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; APPOINTMENTS AND SCHEDULES; BLOOD PRESSURE DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 37049009282     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.172     Document Type: Article

References (15)

1. Neal B. Background paper to chapter 6.3. Priority medicines for Europe and the world (2004), WHO. http://mednet3.who.int/prioritymeds/report/background/cardiovascular.doc http://mednet3.who.int/prioritymeds/report/background/cardiovascular.doc. Accessed: Oct 03, 2006
2. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 357 9261 (2001) 995-1001
3. Smith Jr. S.C., Jackson R., Pearson T.A., et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 109 25 (2004) 3112-3121
4. Schroeder K., Fahey T., and Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 164 7 (2004) 722-732
5. Mulrow C.D., and Pignone M. What are the elements of good treatment for hypertension?. BMJ 322 7294 (2001) 1107-1109
6. Himmelmann A., Hansson L., and Hedner T. Blood pressure measurement: a century of achievements and improvements in the year 2002. Blood Press 11 6 (2002) 325-327
7. Adelswärd V., and Sachs L. Risk discourse: recontextualization of numerical values in clinical practice. Text 18 2 (1998) 191-210
8. Kjellgren K.I., Svensson S., Ahlner J., and Säljö R. Antihypertensive medication in clinical encounters. Int J Cardiol 64 2 (1998) 161-169
9. Kjellgren K.I., Svensson S., Ahlner J., and Säljö R. Antihypertensive treatment and patient autonomy - the follow-up appointment as a resource for care. Patient Educ Couns 40 1 (2000) 39-49
10. Elwyn G., and Gwyn R. Narrative based medicine: stories we hear and stories we tell: analysing talk in clinical practice. BMJ 318 7177 (1999) 186-188
11. Linell P. Approaching dialogue: talk, interaction and contexts in dialogical perspectives (1998), John Benjamins Publishing, Amsterdam
12. Svensson S, Kjellgren KI, Linell P. Negotiating side effects in follow-up appointments for hypertension (manuscript, 2006).
13. Verdecchia P., Reboldi G.P., Angeli F., et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 45 2 (2005) 203-208
14. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf Accessed: Oct 03, 2006
15. Britten N. Lay views of drugs and medicines: orthodox and unorthodox accounts. In: Williams S., and Calnan M. (Eds). Modern medicine: lay perspectives and experiences (1996), UCL Press, London